
Curida is a Contract Development and Manufacturing Organization (CDMO) within the Pharmaceutical and Diagnostic industry, based in Norway.
Description
Curida is specialized in development activities and full-scale commercial manufacturing of aseptic, sterile and non-sterile fill & finish. We have core competence in manufacturing of liquid pharmaceuticals: Blow-Fill-Seal (BFS) and Nasal Sprays. Curida also has a Bio-CDMO unit with GMP ready manufacturing facilities for monoclonal antibodies, serving the IVD industry and Pre-clinical stage companies
Type of Drugs Manufactured:
Small Molecule;Biologics;Medical Devices
CDMO Services:
Aseptic Fill Finish;Research & Development;Clinical Trials materials and logistics;Analytical Development
No. of Manufacturing Facilities:
3-5
High Potent Products capabilities:
OEB 3;OEB 4-5
Facilities Locations:
Europe
Regulatory Approvals for facilities:
EMA (Europe);ISO;GMP;NMPA (China);Health Canada
Manufacturing Technologies:
Blow-Fill-Seal (BFS);Inhalers;Liquids
Current Capacity:
Curida has available capacity in BFS ampoules and Nasal Sprays due to the recent investments made to increase our capacities.
Contact Information
Website
Phone
Address
Fornebu , Martin Linges vei 25, 1364, Norway
Zip/Post Code
1364
AI and Digital Manufacturing Benchmarking Survey
Take this quick 5 minute assessment to benchmark your organisation’s digital and AI maturity — and see how you compare with industry peers.